Cargando…

High Bleeding Risk Patients Treated with Very Thin-Strut Biodegradable Polymer or Thin-Strut Durable Polymer Drug-Eluting Stents in the BIO-RESORT Trial

PURPOSE: Patients with high bleeding risk (HBR) who undergo percutaneous coronary intervention also have an increased risk of ischemic events and represent an overall high-risk population. The coating of durable polymer drug-eluting stents (DP-DES) may induce inflammation and delay arterial healing,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zocca, Paolo, Kok, Marlies M., van der Heijden, Liefke C., Danse, Peter W., Schotborgh, Carl E., Scholte, Martijn, Hartmann, Marc, Linssen, Gerard C. M., Doggen, Carine J. M., von Birgelen, Clemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267643/ https://www.ncbi.nlm.nih.gov/pubmed/30143879 http://dx.doi.org/10.1007/s10557-018-6823-9

Ejemplares similares

Outcome of percutaneous coronary intervention using ultrathin-strut biodegradable polymer sirolimus-eluting versus thin-strut durable polymer zotarolimus-eluting stents in patients with comorbid peripheral arterial disease: a post-hoc analysis from two randomized trials
por: Pinxterhuis, Tineke H., et al.
Publicado: (2023)

Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020)

Biodegradable polymer-coated thin strut sirolimus-eluting stent versus durable polymer-coated everolimus-eluting stent in the diabetic population
por: Gasior, Pawel, et al.
Publicado: (2021)

Safety and efficacy of biodegradable polymer-coated thin strut sirolimus-eluting stent vs. durable polymer-coated everolimus-eluting stent in patients with acute myocardial infarction
por: Gąsior, Paweł, et al.
Publicado: (2018)

Ultrathin-strut biodegradable polymer versus durable polymer drug-eluting stents: a meta-analysis
por: Monjur, Mohammad Riashad, et al.
Publicado: (2020)

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes
por: Menown, Ian B. A., et al.
Publicado: (2021)

Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
por: Ploumen, Eline H., et al.
Publicado: (2022)

Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
por: Ploumen, Eline H., et al.
Publicado: (2021)

Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials
por: Zhu, Ping, et al.
Publicado: (2018)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial
por: Zbinden, Rainer, et al.
Publicado: (2016)

Flexibility of Biodegradable Polymer Stents with Different Strut Geometries
por: Chen, Chong, et al.
Publicado: (2020)

Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study
por: Matsuhiro, Yutaka, et al.
Publicado: (2022)

Clinical outcomes of ultrathin strut biodegradable polymer-coated everolimus-eluting stent in patients with coronary artery disease
por: Patted, Suresh V., et al.
Publicado: (2020)

Investigating the Equivalent Plastic Strain in a Variable Ring Length and Strut Width Thin-Strut Bioresorbable Scaffold
por: Hoddy, Ben, et al.
Publicado: (2022)

Short-term healing response after implantation of the thin-strut, fast-releasing sirolimus-eluting biodegradable polymer-coated Alex Plus stent: optical coherence tomography study
por: Dobrolińska, Magdalena, et al.
Publicado: (2020)

Arterial Healing 10 Months After Implantation of an Ultrathin-Strut, Biodegradable-Polymer, Sirolimus-Eluting Stent　― An Angioscopic Study ―
por: Tsujimura, Takuya, et al.
Publicado: (2021)

Five-year comparative study of thin-strut rapamycin-eluting bioabsorbable scaffold with metallic drug-eluting stent in porcine coronary artery
por: Liu, Yaokun, et al.
Publicado: (2022)

One-year performance of thin-strut cobalt chromium sirolimus-eluting stent versus thicker strut stainless steel biolimus-eluting coronary stent: a propensity-matched analysis of two international all-comers registries
por: Vlieger, Selina, et al.
Publicado: (2020)

The Outcome of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Coronary Artery Disease Patients – A Feasibility Study
por: Panduranga, Prashanth, et al.
Publicado: (2023)

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
por: Ploumen, Eline H., et al.
Publicado: (2021)

Final 5-Year Results in Randomized Japanese Patients Implanted With a Thin-Strut, Bioabsorbable, Polymer-Coated, Everolimus-Eluting SYNERGY Stent (From the EVOLVE II Study)
por: Kimura, Takeshi, et al.
Publicado: (2020)

Prospective evaluation of an ultrathin strut biodegradable polymer-coated sirolimus-eluting stent: 12 months’ results from the S-FLEX UK registry
por: Choudhury, Anirban, et al.
Publicado: (2019)

Ultrathin Strut Biodegradable Polymer-Coated Sirolimus-Eluting Coronary Stents: Patient-Level Pooled Analysis From Two Indian Registries
por: Babu Pothineni, Ramesh, et al.
Publicado: (2023)

Selective Laser Melting Strategy for Fabrication of Thin Struts Usable in Lattice Structures
por: Vrána, Radek, et al.
Publicado: (2018)

Procedural advantages of a novel coronary stent design with ultra-thin struts and bioabsorbable abluminal polymer coating in an all-comers registry
por: Abu Sharar, Haitham, et al.
Publicado: (2018)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019)

Clinical Outcomes of World’s Thinnest (50 μmr) Strut Biodegradable Polymer Coated Everolimus-Eluting Coronary Stent System in Real-World Patients
por: Patted, Suresh V., et al.
Publicado: (2018)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
por: Ajmera, Prakash, et al.
Publicado: (2019)

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review
por: Leone, Attilio, et al.
Publicado: (2022)

Jakarta Struts cookbook
por: Sigglekow, Bill
Publicado: (2005)

Programming Jakarta Struts
por: Cavaness, Chuck
Publicado: (2004)

Programming Jakarta Struts
por: Cavaness, Chuck
Publicado: (2003)

Struts 2 in action
por: Brown, Donald, et al.
Publicado: (2008)

Struts kick start
por: Turner, James, et al.
Publicado: (2003)

Impact of Statin Treatment on Strut Coverage after Drug-Eluting Stent Implantation
por: Suh, Yongsung, et al.
Publicado: (2015)

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial
por: van Houwelingen, K. Gert, et al.
Publicado: (2016)

Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?
por: Gherasie, Flavius-Alexandru, et al.
Publicado: (2023)

Safety and Efficacy of Post-Dilation in Percutaneous Coronary Intervention Using Polymer-Free Ultrathin Strut Sirolimus-Probucol Coated Drug-Eluting Stents
por: Shin, Yonghoon, et al.
Publicado: (2023)

Long-term outcomes following drug-eluting balloon or thin-strut drug-eluting stents for treatment of in-stent restenosis stratified by duration of dual antiplatelet therapy (DEB-Dragon Registry)
por: Januszek, Rafał, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qbcj5lj0ssgf2mauti2lopsj3t